References
Appleby JL. Why doctors must grapple with health economics. British Medical Journal 294: 326, 1987
Association of the British Pharmaceutical Industry. Pharma facts and figures. ABPI, London, 1990
Culyer AJ. The promise of a reformed NHS: an economist’s angle. British Medical Journal 302: 1253–1256, 1991
Department of Health. Improving prescribing, the implementation of the GP Indicative Prescribing Scheme. Department of Health. London. 1990
Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes, Oxford Medical Publications, Oxford, New York, Toronto, 1987
Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. PharmacoEconomics 1(1): 20–32, 1992
Hillman AL, Eisenberg JM, Pauly MV, Bloom BS, Glick H, et al. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. New England Journal of Medicine 324: 1362–1365, 1991
Office of Health Economics. Compendium of Health Statistics, 7th ed., OHE, London, 1989
Parkin D. In providing health care, the economics of alternative systems of finance and delivery. In McGuire A, et al. (Eds) Comparing health service efficiency across countries, Oxford University Press, 1991
Smith R. Where is the wisdom? The poverty of medical evidence. British Medical Journal 303: 798–799, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wells, N. Economic Evaluation of Drugs. Pharmacoeconomics 1, 14–19 (1992). https://doi.org/10.2165/00019053-199201010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199201010-00005